| Description: |
Traditional approaches to drug discovery have focussed on
making and testing large number of compounds in the laboratory.
Inhibox, however, is based on using novel software to screen large
libraries of molecules against therapeutic targets in order to
predict which molecules are likely to be appropriate candidates for
new drugs. This combination of screening software, very large
compound libraries and computing power enables Inhibox to undertake
a range of drug discovery services and collaborations. Inhibox is
also undertaking a number of proprietary programmes. |